Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page
- Check5 days agoChange DetectedRevision upgraded from v3.5.3 to v3.5.4, signaling a small internal update to the page’s tooling. No substantive content changes to the study details are indicated by this update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, indicating a minor update to the page record rather than substantive changes to the study information.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedSite revision updated to v3.5.2; v3.5.0 was removed.SummaryDifference0.1%

- Check55 days agoChange DetectedAdded Type 2 diabetes as a related topic and included MedlinePlus Genetics as related topics. Updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check62 days agoChange DetectedRemoved related topics tags: 'Type 2 diabetes' and 'MedlinePlus Genetics' from the study page.SummaryDifference0.2%

- Check69 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.